167 related articles for article (PubMed ID: 19607846)
1. Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system.
Lafenêtre P; Chaouloff F; Marsicano G
Neuropharmacology; 2009 Dec; 57(7-8):715-21. PubMed ID: 19607846
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission.
Jacob W; Yassouridis A; Marsicano G; Monory K; Lutz B; Wotjak CT
Genes Brain Behav; 2009 Oct; 8(7):685-98. PubMed ID: 19563475
[TBL] [Abstract][Full Text] [Related]
3. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses.
Steiner MA; Marsicano G; Wotjak CT; Lutz B
Psychoneuroendocrinology; 2008 Sep; 33(8):1165-70. PubMed ID: 18653287
[TBL] [Abstract][Full Text] [Related]
4. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance.
Quarta C; Bellocchio L; Mancini G; Mazza R; Cervino C; Braulke LJ; Fekete C; Latorre R; Nanni C; Bucci M; Clemens LE; Heldmaier G; Watanabe M; Leste-Lassere T; Maitre M; Tedesco L; Fanelli F; Reuss S; Klaus S; Srivastava RK; Monory K; Valerio A; Grandis A; De Giorgio R; Pasquali R; Nisoli E; Cota D; Lutz B; Marsicano G; Pagotto U
Cell Metab; 2010 Apr; 11(4):273-85. PubMed ID: 20374960
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system and the treatment of obesity.
Pagotto U; Vicennati V; Pasquali R
Ann Med; 2005; 37(4):270-5. PubMed ID: 16019725
[TBL] [Abstract][Full Text] [Related]
7. Neuromodulatory functions of the endocannabinoid system.
Marsicano G; Lutz B
J Endocrinol Invest; 2006; 29(3 Suppl):27-46. PubMed ID: 16751707
[TBL] [Abstract][Full Text] [Related]
8. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
Hungund BL; Basavarajappa BS
Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
[TBL] [Abstract][Full Text] [Related]
9. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
11. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
12. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons.
Hill EL; Gallopin T; Férézou I; Cauli B; Rossier J; Schweitzer P; Lambolez B
J Neurophysiol; 2007 Apr; 97(4):2580-9. PubMed ID: 17267760
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid system and stress and anxiety responses.
Viveros MP; Marco EM; File SE
Pharmacol Biochem Behav; 2005 Jun; 81(2):331-42. PubMed ID: 15927244
[TBL] [Abstract][Full Text] [Related]
14. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures.
Lutz B
Biochem Pharmacol; 2004 Nov; 68(9):1691-8. PubMed ID: 15450934
[TBL] [Abstract][Full Text] [Related]
15. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
Engler B; Freiman I; Urbanski M; Szabo B
J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
[TBL] [Abstract][Full Text] [Related]
16. The role of endocannabinoids in the hypothalamic regulation of visceral function.
Wenger T; Moldrich G
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):301-7. PubMed ID: 12052044
[TBL] [Abstract][Full Text] [Related]
17. Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration.
Häring M; Kaiser N; Monory K; Lutz B
PLoS One; 2011; 6(11):e26617. PubMed ID: 22069458
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling.
Kamprath K; Plendl W; Marsicano G; Deussing JM; Wurst W; Lutz B; Wotjak CT
Genes Brain Behav; 2009 Mar; 8(2):203-11. PubMed ID: 19077175
[TBL] [Abstract][Full Text] [Related]
19. Bimodal control of fear-coping strategies by CB₁ cannabinoid receptors.
Metna-Laurent M; Soria-Gómez E; Verrier D; Conforzi M; Jégo P; Lafenêtre P; Marsicano G
J Neurosci; 2012 May; 32(21):7109-18. PubMed ID: 22623656
[TBL] [Abstract][Full Text] [Related]
20. Bimodal control of stimulated food intake by the endocannabinoid system.
Bellocchio L; Lafenêtre P; Cannich A; Cota D; Puente N; Grandes P; Chaouloff F; Piazza PV; Marsicano G
Nat Neurosci; 2010 Mar; 13(3):281-3. PubMed ID: 20139974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
